Diazaborines Are a Versatile Platform to Develop ROS-Responsive Antibody Drug Conjugates*.
António JPM, Carvalho JI, André AS, Dias JNR, Aguiar SI, Faustino H, Lopes RMRM, Veiros LF, Bernardes GJL, da Silva FA, Gois PMP.
António JPM, et al. Among authors: faustino h.
Angew Chem Int Ed Engl. 2021 Dec 1;60(49):25914-25921. doi: 10.1002/anie.202109835. Epub 2021 Nov 5.
Angew Chem Int Ed Engl. 2021.
PMID: 34741376